⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL503841 | 1.00 | — | — | |
| SCHEMBL14394636 | 1.00 | — | — | |
| SCHEMBL14775418 | 0.81 | SOAT1 (0.39) | — | |
| SCHEMBL983669 | 0.81 | SOAT1 (0.39) | — | |
| SCHEMBL6550235 | 0.79 | — | — | |
| SCHEMBL386857 | 0.79 | — | — | |
| SCHEMBL16797521 | 0.79 | — | — | |
| SCHEMBL531365 | 0.78 | — | — | |
| SCHEMBL702705 | 0.78 | — | — | |
| SCHEMBL531366 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 344 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240182631-A1 | RANDOM COPOLYMER AND METHOD OF PRODUCING SAME | ZEON CORPORATION (JP) | 2024-06-06 | — | — | US | claimed |
| EP-4317241-A1 | RANDOM COPOLYMER AND METHOD FOR MANUFACTURING SAME | Zeon Corporation (JP) | 2024-02-07 | — | — | EP | claimed |
| CN-116964124-A | Random copolymer and method for producing same | 日本瑞翁株式会社 | 2023-10-27 | — | — | CN | claimed |
| WO-2022210407-A1 | RANDOM COPOLYMER AND METHOD FOR MANUFACTURING SAME | 日本ゼオン株式会社 | 2022-10-06 | — | — | WO | claimed |
| WO-2022210411-A1 | RANDOM COPOLYMER AND METHOD FOR PRODUCING SAME | 日本ゼオン株式会社 | 2022-10-06 | — | — | WO | claimed |
| WO-2022210409-A1 | RANDOM COPOLYMER AND METHOD FOR PRODUCING SAME | 日本ゼオン株式会社 | 2022-10-06 | — | — | WO | claimed |
| CN-102083918-A | Surface-promoted cure of one-part cationically curable compositions | LOCTITE R & D LTD | 2011-06-01 | — | — | CN | claimed |
| EP-2288665-A1 | SURFACE-PROMOTED CURE OF ONE-PART CATIONICALLY CURABLE COMPOSITIONS | Loctite (R & D) Limited (IE) | 2011-03-02 | — | — | EP | claimed |
| WO-2009141444-A1 | SURFACE-PROMOTED CURE OF ONE-PART CATIONICALLY CURABLE COMPOSITIONS | LOCTITE (R&D) LIMITED (IE) | 2009-11-26 | — | — | WO | claimed |
| US-20090288769-A1 | Surface-Promoted Cure of Cationically Curable Compositions Comprising Vinyl Ethers | LOCTITE (R&D)LIMITED (IE) | 2009-11-26 | — | — | US | claimed |
| EP-4003988-B1 | 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS | SERVIER LAB (FR) | 2026-05-20 | — | — | EP | disclosed |
| EP-3805327-B1 | ANTIFOULING PAINT COMPOSITION | MITSUBISHI CHEM CORP (JP) | 2026-04-15 | — | — | EP | disclosed |
| EP-3870960-B1 | CHEMICAL LIQUID MANUFACTURING APPARATUS AND METHOD OF MANUFACTURING CHEMICAL LIQUID | FUJIFILM ELECTRONIC MAT USA INC (US) | 2026-04-15 | — | — | EP | disclosed |
| US-20260079169-A1 | VOLATILE ORGANIC COMPOUNDS AS MARKERS FOR CELLULAR COMMUNICATION | TECHNION RES & DEV FOUNDATION (IL) | 2026-03-19 | — | — | US | disclosed |
| EP-3883663-B9 | CHEMICAL LIQUID MANUFACTURING APPARATUS AND MANUFACTURING METHOD OF CHEMICAL LIQUID | FUJIFILM ELECTRONIC MAT USA INC (US) | 2026-02-25 | — | — | EP | disclosed |
| WO-1999041245-A1 | INSECTICIDAL DIHYDRO-OXADIAZINES, -THIADIAZINES AND -TRIAZINES | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1999-08-19 | — | — | WO | disclosed |
| EP-0873788-A2 | An azo compound as a catalyst for formation of a carbon-carbon bond and a method for the formation of such a bond | Wako Pure Chemical Industries, Ltd. (JP) | 1998-10-28 | — | — | EP | disclosed |
| US-5767128-A | ANALGESICS | ADIR ET COMPAGNIE (FR) | 1998-06-16 | — | — | US | disclosed |
| US-5618819-A | ANALGESICS | ADIR ET COMPAGNIE (FR) | 1997-04-08 | — | — | US | disclosed |
| CN-1127254-A | New 1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2(3H)-one compounds, a process for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1996-07-24 | — | — | CN | disclosed |